No Data
No Data
Merck's (MRK) New Pneumococcal Jab Capvaxive Gets CDC Panel Vote
Annovis Bio Files Provisional Patent for New Manufacturing Process of Crystalline Form of Buntanetap
Express News | Annovis Bio Inc: Files Patent for New Composition of Matter for Buntanetap
Express News | Annovis Bio Files New Patent for Novel Solid Forms of Buntanetap With U.S. Patent Office; Builds on Provisional Patent From June 2023
Annovis Bio Files Patent for New Composition of Matter for Buntanetap
Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast to Discuss Parkinson's Disease Data